ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

278.8592 0 (+0.0000%) 10/10/2017 11:00am
Open: N/A Prev Close: 278.8592
High: N/A Low: N/A
Volume: 248 Market Cap: 29.18B
Year High: 286.3000 Year Low: 138.0100
Stock Technical Analysis
Targets Six months: 327.0400    One year: 381.9827
Supports Support1: 277.8061   Support2: 276.4500
Resistances Resistance1: 280.0000    Resistance2: 327.0400 
Pivot Point 277.7106 
Moving Averages MA(5): 277.6218      MA(20): 277.7830 

MA(100): 279.4600  -1     MA(250): 249.1895 
MACD MACD(12,26): -0.312      Signal(12,26,9): -0.349 
Stochastic Oscillator %K(14,3): 25.908      %D(3): 24.755 
RSI RSI(14): 54.760 
52-Week High: 286.3000  Low: 138.0100  Change(%): 62
Average Volume(K) 3-Month: 23  10-Days: 1
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed below upper band by 23.7%; above bottom band by 76.3%; Bollinger Bands are 32.7% narrower than normal.The current width of the bands does not suggest anything about the future direction or movement of prices.


Stock Chart

Top 100 stocks

Stock News
Actelion, J&J Are Back in Exclusive Talks a Week After Breakup
Wed, 21 Dec 2016 18:44:13 GMT

Sanofi Said to Hold Talks With Actelion After J&J Walks Away
Wed, 14 Dec 2016 08:22:44 GMT

J&J, Actelion Said to Reach Tentative Agreement on Price
Wed, 11 Jan 2017 21:20:22 GMT

Publication of the provisional notice of the end result of Actelion tender offer
Mon, 24 Apr 2017 04:52:30 GMT

Johnson & Johnson publishes interim result for Actelion tender offer and ...
Fri, 31 Mar 2017 04:52:30 GMT

Actelion announces excellent financial results for 2016
Tue, 14 Feb 2017 06:00:00 GMT

Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker
Fri, 02 Dec 2016 08:48:45 GMT

Actelion Using Combination Strategy to Attack Multiple Sclerosis
Thu, 20 Oct 2016 09:11:15 GMT

J&J Raises Takeover Offer for Europe's Largest Biotech Firm Actelion
Tue, 29 Nov 2016 14:56:48 GMT

Sanofi Sees No Opening to Actelion Talks After J&J Re-Entry
Mon, 09 Jan 2017 18:56:15 GMT